Evidence map›Paper›PMID 41183040›Full record

ArticlePloS one2025

Integrating genomic epidemiology and deep mutational scanning data for prevalence forecasting of SARS-CoV-2 Omicron lineages.

Zhong-Yi Lei, Xiao-Min Zhang, Jia-Lu Han, Ji-Guo Xue, Jia-Yi Xu, Zi-Lin Ren, Yi-Gang Tong, Xiao-Chen Bo, Ming Ni

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhong-Yi LeiCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Xiao-Min ZhangAdvanced & Interdisciplinary Biotechnology, Academy of Military Medical Sciences, Beijing, China.
Jia-Lu HanChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun, China.
Ji-Guo XueAdvanced & Interdisciplinary Biotechnology, Academy of Military Medical Sciences, Beijing, China.
Jia-Yi XuCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Zi-Lin RenChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun, China.
Yi-Gang TongCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
Xiao-Chen BoAdvanced & Interdisciplinary Biotechnology, Academy of Military Medical Sciences, Beijing, China.
Ming NiAdvanced & Interdisciplinary Biotechnology, Academy of Military Medical Sciences, Beijing, China.ORCID https://orcid.org/0000-0001-9465-2787

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continuously circulates and the Omicron variants have mutated into over 2,500 lineages, predicting ensuing prevalent lineages and inflections of dominant lineages is of public health significance and study interest. Previous study has integrated genome to forecast lineage prevalence, yet overlooked the functional aspects of mutations; efforts to evaluate the functional effects of individual mutations have not extended to the lineage level. Here, we propose CoVPF, a model integrating both genomic epidemiology and deep mutational scanning (DMS) data for the receptor binding domain (RBD) of SARS-CoV-2 spike protein, to predict the prevalence of Omicron lineages. Retrospective validation demonstrated that CoVPF achieved 20.7% higher accuracy compared to previous study. Furthermore, we found that accounting for epistasis was critical, as ignoring epistasis led to a 43% decrease in forecasting accuracy. Case studies showed that CoVPF delivered more accurate and timely forecasts for lineage expansions and inflections such as EG.5.1 and XBB.1.5. CoVPF provides a paradigm for integrating in vitro functional readouts of the virus and accounting for combinatorial effects of mutations in support of public health efforts in lineage prevalence forecasting.

Indexed as

COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusEpistasis, GeneticForecastingGenome, ViralGenomicsHumansMutationPrevalenceSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID41183040
PMCPMC12582474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.